FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384488712> ?p ?o ?g. }

• W4384488712 endingPage "4393" @default.
• W4384488712 startingPage "4381" @default.
• W4384488712 abstract "Chemotherapeutic exposures are associated with subsequent malignant neoplasm (SMN) risk. The role of genetic susceptibility in chemotherapy-related SMNs should be defined as use of radiation therapy (RT) decreases.SMNs among long-term childhood cancer survivors of European (EUR; N = 9,895) and African (AFR; N = 718) genetic ancestry from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study were evaluated. An externally validated 179-variant polygenic risk score (PRS) associated with pleiotropic adult cancer risk from the UK Biobank Study (N > 400,000) was computed for each survivor. SMN cumulative incidence comparing top and bottom PRS quintiles was estimated, along with hazard ratios (HRs) from proportional hazards models.A total of 1,594 survivors developed SMNs, with basal cell carcinomas (n = 822), breast cancers (n = 235), and thyroid cancers (n = 221) being the most frequent. Although SMN risk associations with the PRS were extremely modest in RT-exposed EUR survivors (HR, 1.22; P = .048; n = 4,630), the increase in 30-year SMN cumulative incidence and HRs comparing top and bottom PRS quintiles was statistically significant among nonirradiated EUR survivors (n = 4,322) treated with alkylating agents (17% v 6%; HR, 2.46; P < .01), anthracyclines (20% v 8%; HR, 2.86; P < .001), epipodophyllotoxins (23% v 1%; HR, 12.20; P < .001), or platinums (46% v 7%; HR, 8.58; P < .01). This PRS also significantly modified epipodophyllotoxin-related SMN risk among nonirradiated AFR survivors (n = 414; P < .01). Improvements in prediction attributable to the PRS were greatest for epipodophyllotoxin-exposed (AUC, 0.71 v 0.63) and platinum-exposed (AUC,0.68 v 0.58) survivors.A pleiotropic cancer PRS has strong potential for improving SMN clinical risk stratification among nonirradiated survivors treated with specific chemotherapies. A polygenic risk screening approach may be a valuable complement to an early screening strategy on the basis of treatments and rare cancer-susceptibility mutations." @default.
• W4384488712 created "2023-07-17" @default.
• W4384488712 creator A5006883212 @default.
• W4384488712 creator A5008672006 @default.
• W4384488712 creator A5013768212 @default.
• W4384488712 creator A5029618376 @default.
• W4384488712 creator A5036451685 @default.
• W4384488712 creator A5036811836 @default.
• W4384488712 creator A5037634832 @default.
• W4384488712 creator A5038361086 @default.
• W4384488712 creator A5043738456 @default.
• W4384488712 creator A5054442842 @default.
• W4384488712 creator A5059262359 @default.
• W4384488712 creator A5065573166 @default.
• W4384488712 creator A5066041865 @default.
• W4384488712 creator A5075761718 @default.
• W4384488712 creator A5085263272 @default.
• W4384488712 creator A5087733065 @default.
• W4384488712 creator A5089743648 @default.
• W4384488712 date "2023-09-20" @default.
• W4384488712 modified "2023-10-17" @default.
• W4384488712 title "Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report" @default.
• W4384488712 cites W1833470471 @default.
• W4384488712 cites W1839076539 @default.
• W4384488712 cites W1903927332 @default.
• W4384488712 cites W1996131136 @default.
• W4384488712 cites W2004799731 @default.
• W4384488712 cites W2015410907 @default.
• W4384488712 cites W2029803535 @default.
• W4384488712 cites W2037066552 @default.
• W4384488712 cites W2041344443 @default.
• W4384488712 cites W2050537989 @default.
• W4384488712 cites W2058217833 @default.
• W4384488712 cites W2062010938 @default.
• W4384488712 cites W2073140442 @default.
• W4384488712 cites W2082704080 @default.
• W4384488712 cites W2083500054 @default.
• W4384488712 cites W2087023624 @default.
• W4384488712 cites W2101807916 @default.
• W4384488712 cites W2102203460 @default.
• W4384488712 cites W2109242212 @default.
• W4384488712 cites W2111345124 @default.
• W4384488712 cites W2111386972 @default.
• W4384488712 cites W2136264604 @default.
• W4384488712 cites W2144906623 @default.
• W4384488712 cites W2147606107 @default.
• W4384488712 cites W2152710213 @default.
• W4384488712 cites W2161633633 @default.
• W4384488712 cites W2168571815 @default.
• W4384488712 cites W2171545351 @default.
• W4384488712 cites W2198590456 @default.
• W4384488712 cites W2323716083 @default.
• W4384488712 cites W2333611917 @default.
• W4384488712 cites W2504048115 @default.
• W4384488712 cites W2517068497 @default.
• W4384488712 cites W2527896025 @default.
• W4384488712 cites W2588680423 @default.
• W4384488712 cites W2594318825 @default.
• W4384488712 cites W2601822003 @default.
• W4384488712 cites W2602986494 @default.
• W4384488712 cites W2613151407 @default.
• W4384488712 cites W2618647272 @default.
• W4384488712 cites W2618935666 @default.
• W4384488712 cites W2734395071 @default.
• W4384488712 cites W2806161996 @default.
• W4384488712 cites W2806839780 @default.
• W4384488712 cites W2865362922 @default.
• W4384488712 cites W2886752110 @default.
• W4384488712 cites W2891085289 @default.
• W4384488712 cites W2898267235 @default.
• W4384488712 cites W2901952863 @default.
• W4384488712 cites W2913869848 @default.
• W4384488712 cites W2923926791 @default.
• W4384488712 cites W2950546139 @default.
• W4384488712 cites W2951135001 @default.
• W4384488712 cites W2964217224 @default.
• W4384488712 cites W2970754556 @default.
• W4384488712 cites W2980780905 @default.
• W4384488712 cites W3004603152 @default.
• W4384488712 cites W3024294833 @default.
• W4384488712 cites W3036784533 @default.
• W4384488712 cites W3045441625 @default.
• W4384488712 cites W3081325588 @default.
• W4384488712 cites W3083488708 @default.
• W4384488712 cites W3087161268 @default.
• W4384488712 cites W3088258981 @default.
• W4384488712 cites W3106839128 @default.
• W4384488712 cites W3114059671 @default.
• W4384488712 cites W3115151307 @default.
• W4384488712 cites W3196982414 @default.
• W4384488712 cites W4283073652 @default.
• W4384488712 cites W4289260965 @default.
• W4384488712 doi "https://doi.org/10.1200/jco.23.00428" @default.
• W4384488712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37459583" @default.
• W4384488712 hasPublicationYear "2023" @default.
• W4384488712 type Work @default.
• W4384488712 citedByCount "0" @default.
• W4384488712 crossrefType "journal-article" @default.

• next